Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04965857
Other study ID # BTS1650_20
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 1, 2021
Est. completion date December 31, 2023

Study information

Verified date July 2023
Source Hologic Deutschland GmbH
Contact Henrik Griesser, Prof. Dr.
Phone +49 (0)221 940 505 840
Email info@zotzklimas.de
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Quality assurance of the laboratory examinations. Prospective non-interventional study with ThinPrep slides collected during the German Co-Screening Program and routinely sent to the lab to prospectively evaluate the clinical performance of the Hologic Genius Digital Cytology (DC) system vs. the liquid-based cytology (LBC) manual microscopic approach


Description:

The cause of cervical cancer is a persistent infection with high-risk types of human papillomavirus (HPV). Cytology has been the gold standard for cervical screening since the introduction of routine screening with the Pap test in the 1950s due to its effect on mortality in regions with screening programs. Since that time, there have been several technological advances (LBC, Imaging) to improve and automate cervical cytology, resulting in increased disease detection and efficiency. The Hologic's Genius Digital Diagnostics System is a CE-IVD (CE-marked in vitro diagnostic device) marked digital cytology platform. For quality assurance and to prospectively evaluate the Hologic Genius Digital Cytology (DC) system in the lab, selected routinely screened and already archived slides will be additionally reviewed with the liquid-based cytology (LBC) manual microscopic approach. Only anonymized results will be evaluated.


Recruitment information / eligibility

Status Recruiting
Enrollment 3000
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers
Gender Female
Age group 35 Years to 90 Years
Eligibility Inclusion Criteria: - LBC ThinPrep® samples are collected by gynaecologists and sent routinely to cytology laboratory Zotz & Klimas as part of the German Cervical cancer screening program.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Hologic's Genius Digital Diagnostics System
Genius Digital Diagnostics is a digital cytology platform to combine a new artificial intelligence (AI) algorithm with advanced volumetric imaging technology to help cytotechnologists and pathologists identify pre-cancerous lesions and cancer cells in women.

Locations

Country Name City State
Germany Zotz Klimas Partner für Diagnostik und Prävention MVZ Düsseldorf-Centrum Düsseldorf

Sponsors (1)

Lead Sponsor Collaborator
Hologic Deutschland GmbH

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sensitivity and specificity of detection of pre-cancerous lesions using Hologic Genius Digital Cytology Imaging scanner. To demonstrate non-inferiority, the appropriate approximative one-sided 95% confidence interval for the true difference between the two approaches (Digital Cytology and Manual microscopic reading) will be constructed. 1 year
Secondary To assess the rate of inadequate slides that cannot be read by the Hologic Genius Digital Cytology system. 1 year
Secondary Change in time needed to screen 80 slides using Hologic Genius Digital Cytology Imaging scanner. To assess the impact on the workflow of the introduction of a Digital Cytology procedure to a high-throughput screening lab in Germany. 1 year
Secondary Clinical performance of Hologic Genius Digital Cytology Imaging scanner using cells on a ThinPrep® slide. The performance of Hologic Genius Digital Cytology Imaging scanner during cervical cancer screening (using histology as reference method) will be assessed via sensitivity, specificity, positive and negative predictive values. 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05092022 - St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic N/A
Completed NCT00933140 - Anal HPV Infection and Abnormal Cytology in HIV-infected Women N/A
Recruiting NCT05314907 - Acceptability of Self-sampling for Cervical Cancer Screening N/A
Recruiting NCT04650711 - Immunohistochemical Staining of p16 for the Screening of Cervical Cancer Phase 2
Recruiting NCT06178549 - Emergency Room HPV Self-Sampling Study (ACT NOW) N/A
Recruiting NCT06204133 - Model Study on Cervical Cancer Screening Strategies and Risk Prediction
Completed NCT04237883 - Primary Care Clinical Excellence Incentive Study N/A
Not yet recruiting NCT03750214 - Evaluation of the Biop Colposcopy System's Safety and Performance (Accuracy of Its Registration Procedure) N/A
Completed NCT03222817 - HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals N/A
Not yet recruiting NCT05426642 - The Effect of E-health Video Towards Enhancing Cervical Cancer Screening N/A
Completed NCT00461760 - HPV Testing for Cervical Cancer Screening Study N/A
Not yet recruiting NCT05286034 - Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme N/A
Recruiting NCT05256862 - Improving Cervical Cancer Screening in Women Living With HIV Attending Chronic Disease Clinics in Semi-rural Tanzania
Recruiting NCT05762757 - Patient-centered Educational Material to Improve Colposcopy Adherence N/A
Completed NCT02273206 - Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women N/A
Completed NCT03466710 - Post Colposcopy Management of ASC-US and LSIL Pap Tests N/A
Completed NCT01287871 - Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer N/A
Completed NCT00224224 - A Comparison of Primary Care and Traditional Internal Medicine Residents N/A
Not yet recruiting NCT06229275 - Study to Evaluate the Effectiveness of the Personal Pap Smear Device™ for Collection of Cervical Cells Phase 3
Completed NCT03012932 - HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women N/A